Global Bioactive Glass Implants Market Growth 2025-2031

The global Bioactive Glass Implants market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Bioactive glass is a type of glass made from high-purity chemicals such as silica, calcium, and boron that has unique biological activity. After the bioactive glass is implanted in the body, its surface undergoes an ionic reaction with body fluids, eventually forming a low-crystalline carbonated hydroxyapatite layer similar to the inorganic minerals in bone on the glass surface. Because the chemical composition of bioactive glass is similar to that of bones in living organisms, it is easy to form strong chemical bonds with surrounding bones. It has excellent osteoinductivity, osteoconductivity and biocompatibility. It has been widely used in biological tissue engineering and bone transplantation. , tooth regeneration, wound healing and other biomedical fields.

In recent years, a series of bioactive glasses with specific properties, such as phosphate porous crystallized glass, ferromagnetic glass ceramics and composite materials containing bioglass phases, have been continuously developed, and bioactive glasses have become more widely used.

United States market for Bioactive Glass Implants is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bioactive Glass Implants is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bioactive Glass Implants is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bioactive Glass Implants players cover SCHOTT, Johnson & Johnson (DePuy Synthes), NovaBone, MO-SCI, Ferro (Vibrantz Technologies), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Bioactive Glass Implants Industry Forecast” looks at past sales and reviews total world Bioactive Glass Implants sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioactive Glass Implants sales for 2025 through 2031. With Bioactive Glass Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioactive Glass Implants industry.

This Insight Report provides a comprehensive analysis of the global Bioactive Glass Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioactive Glass Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioactive Glass Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioactive Glass Implants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioactive Glass Implants.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioactive Glass Implants market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
S53P4
45S5
Others

Segmentation by Application:
Bone Graft
Tooth Regeneration
Biological Tissue Engineering
Wound Healing
Cosmetic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
SCHOTT
Johnson & Johnson (DePuy Synthes)
NovaBone
MO-SCI
Ferro (Vibrantz Technologies)
Stryker
Noraker
BonAlive Biomaterials
Synergy Biomedical
ZimVie
Zimmer Biomet
Arthrex
Beijing Best life High-Tech
Ugulin
Kunshan Overseas Chinese Technology New Material
Zhangjiagang Bluewisdom Biotechnology
Hubei Dingsheng Technology Development

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bioactive Glass Implants market?

What factors are driving Bioactive Glass Implants market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bioactive Glass Implants market opportunities vary by end market size?

How does Bioactive Glass Implants break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.